Hydrogen peroxide-induced arachidonic acid release in L929 cells; roles of Src, protein kinase C and cytosolic phospholipase A2alpha

Eur J Pharmacol. 2006 Sep 28;546(1-3):1-10. doi: 10.1016/j.ejphar.2006.06.071. Epub 2006 Jul 5.

Abstract

Hydrogen peroxide (H(2)O(2)) stimulates the release of arachidonic acid from cells, but the signaling mechanism(s) involved remains to be elucidated. We investigated the roles of alpha-type cytosolic phospholipase A(2) (cPLA(2)alpha), Src family kinases (Src) and protein kinase C (PKC) in the release of arachidonic acid from L929 cells (a murine fibroblast cell line), C12 cells (a variant of L929 that lacks cPLA(2)alpha) and a stable clone of C12 cells expressing cPLA(2)alpha (C12-cPLA(2)alpha cells). In the presence of 10 muM A23187, 100 nM phorbol myristate acetate (PMA) and 1 mM H(2)O(2) synergistically stimulated arachidonic acid release from L929 cells and C12-cPLA(2)alpha cells, and to a much lesser extent from C12 cells. The reagents alone and co-treatment with PMA and H(2)O(2) without A23187 had marginal effects. No arachidonic acid was released by PMA/A23187 or H(2)O(2)/A23187 in CaCl(2)-free buffer and the release was inhibited by a selective cPLA(2)alpha inhibitor (3 microM pyrrophenone). Addition of 10 microM H(2)O(2), which did not stimulate arachidonic acid release with A23187, enhanced the response to PMA/A23187. The release induced by PMA/A23187 and by H(2)O(2)/A23187 was significantly inhibited by a PKC inhibitor (10 microM GF109203X) and in PKC-depleted cells, and by a Src inhibitor (2 microM PP2). The phosphorylation of extracellular signal-regulated kinase 1/2 induced by PMA/A23187 and H(2)O(2)/A23187 was significantly decreased by inhibitors of PKC and Src. These findings suggest that H(2)O(2) with Ca(2+) stimulates arachidonic acid release via cPLA(2)alpha in a Src- and PKC-dependent manner in L929 cells. The role of cross-talk between Src and PKC in arachidonic acid release is discussed.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonic Acid / metabolism*
  • Calcimycin / pharmacology
  • Calcium / metabolism
  • Cell Line, Tumor
  • Cytosol / metabolism
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Fibroblasts / drug effects*
  • Fibroblasts / metabolism
  • Group IV Phospholipases A2
  • Humans
  • Hydrogen Peroxide / pharmacology*
  • Indoles / pharmacology
  • Ionophores / pharmacology
  • Maleimides / pharmacology
  • Mice
  • Phospholipases A / antagonists & inhibitors
  • Phospholipases A / deficiency
  • Phospholipases A / genetics
  • Phospholipases A / metabolism*
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism*
  • Protein Kinase C-alpha
  • Protein Transport / drug effects
  • Pyrimidines / pharmacology
  • Pyrrolidines / pharmacology
  • Signal Transduction / drug effects
  • Tetradecanoylphorbol Acetate / pharmacology
  • Transfection
  • src-Family Kinases / antagonists & inhibitors
  • src-Family Kinases / metabolism*

Substances

  • AG 1879
  • Enzyme Inhibitors
  • Indoles
  • Ionophores
  • Maleimides
  • Pyrimidines
  • Pyrrolidines
  • pyrrophenone
  • Arachidonic Acid
  • Calcimycin
  • Hydrogen Peroxide
  • protein kinase C gamma
  • src-Family Kinases
  • Protein Kinase C
  • Protein Kinase C-alpha
  • Phospholipases A
  • Group IV Phospholipases A2
  • bisindolylmaleimide I
  • Tetradecanoylphorbol Acetate
  • Calcium